Zsolt Pál Harsányi founded DynPort Vaccine Co. LLC. Presently, he occupies the position of Chairman of Exponential Biotherapies, Inc. and Chairman at N-Gene Research Laboratories, Inc.
He is also on the board of Emergent BioSolutions, Inc., Aptevo Therapeutics, Inc. and OptiFilter Research Zrt.
In his past career he was Chairman & Chief Executive Officer of Exponential Biotherapies, Inc., President of Porton International Plc and Vice President-Corporate Finance at E.F. Hutton & Co., Inc.
Dr. Harsányi received an undergraduate degree from Amherst College and a doctorate from Albert Einstein College of Medicine, Inc.